U.S. Athira Pharma, Lowe's Companies, P&G
Sept 19 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Athira Pharma, Lowe's Companies and P&G on Thursday.
HIGHLIGHTS
* Athira Pharma Inc ATHA.O: Mizuho cuts to neutral from outperform |
* Five Below Inc FIVE.O: JP Morgan cuts to underweight from neutral |
* Lowe's Companies Inc LOW.N: TD Cowen raises target price to $265 from $240 |
* P&G PG.N: JP Morgan raises target price to $186 from $179 |
* SS&C Technologies Holdings Inc SSNC.O: RBC raises target price to $86 from $75 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* 4D Molecular Therapeutics Inc FDMT.O: Chardan Capital Markets raises PT to $39 from $38 |
* 4D Molecular Therapeutics Inc FDMT.O: Leerink Partners cuts PT to $36 from $40 |
* Abbott ABT.N: Piper Sandler initiates coverage with overweight rating; price target $131 |
* Alcoa Corp AA.N: UBS raises target price to $40 from $38 |
* Applied Therapeutics Inc APLT.O: Citigroup raises target price to $11 from $8 |
* Applied Therapeutics Inc APLT.O: Leerink Partners raises target price to $14 from $11 |
* Applovin Corp APP.O: Citigroup raises target price to $155 from $110 |
* Arbor Realty Trust Inc ABR.N: Raymond James raises target price to $16 from $15 |
* Athira pharma Inc ATHA.O: Mizuho cuts target price to $0.5 from $5 |
* Athira pharma Inc ATHA.O: Mizuho cuts to neutral from outperform |
* Avery Dennison Corp AVY.N: BMO cuts target price to $252 from $254 |
* Bank of New York Mellon Corp BK.N: Citigroup raises target price to $70 from $65 |
* Boston Omaha Corp BOC.N: Wells Fargo cuts target price to $15 from $17 |
* Builders Firstsource Inc BLDR.N: BofA Global Research raises price objective to $198 from $165 |
* Builders Firstsource Inc BLDR.N: Wedbush raises target price to $230 from $175 |
* Carmax Inc KMX.N: JP Morgan raises target price to $65 from $55 |
* Carnival Corp CCL.N: Mizuho raises target price to $25 from $22 |
* Casella Waste Systems Inc CWST.O: Raymond James raises target price to $122 from $121 |
* Caseys General Stores Inc CASY.O: JP Morgan cuts to underweight from neutral |
* Caseys General Stores Inc CASY.O: JP Morgan raises target price to $337 from $300 |
* Championx Corp CHX.O: Citigroup raises target price to $45 from $40 |
* Charter Communications Inc CHTR.O: RBC initiates coverage with price target $345 |
* Charter Communications Inc CHTR.O: RBC initiates coverage with sector perform rating |
* Children's Place Inc PLCE.O: UBS raises target price to $18 from $12 |
* Clear Channel Outdoor Holdings Inc CCO.N: Wells Fargo cuts PT to $1.75 from $2.75 |
* Clear Channel Outdoor Holdings Inc CCO.N: Wells Fargo cuts to equal weight from overweight |
* Confluent Inc CFLT.O: UBS cuts target price to $23 from $27 |
* Coursera Inc COUR.N: BofA Global Research initiates coverage with price objective $11 |
* Coursera Inc COUR.N: BofA Global Research initiates coverage with buy rating |
* Deckers Brands DECK.N: Barclays adjusts PT to $180 from $1090 to reflect 6-for-1 stock split |
* Doordash DASH.O: BTIG raises to buy from neutral |
* DR Horton Inc DHI.N: BofA Global Research raises price objective to $215 from $196 |
* Dream Finders Homes DFH.N: BofA Global Research raises price objective to $38 from $35 |
* Driven Brands Holdings Inc DRVN.O: Canaccord Genuity raises PT to $20 from $19 |
* Driven Brands Holdings Inc DRVN.O: Canaccord Genuity raises target price to $20 from $19 |
* Edgewise Therapeutics Inc EWTX.O: Truist Securities raises target price to $33 from $25 |
* Elanco Animal Health Inc ELAN.N: Morgan Stanley cuts target price to $15 from $17 |
* Elanco Animal Health Inc ELAN.N: Morgan Stanley cuts to equal-weight from overweight |
* Enphase Energy Inc ENPH.O: Mizuho cuts target price to $146 from $151 |
* Equity Lifestyle Properties ELS.N: Wells Fargo raises target price to $82 from $70.5 |
* Equity Lifestyle Properties ELS.N: Wells Fargo raises to overweight from equal weight |
* European Wax Center Inc EWCZ.O: Piper Sandler raises target price to $9 from $8 |
* Exelixis Inc EXEL.O: UBS initiates coverage with neutral rating and target price $30 |
* Five Below Inc FIVE.O: JP Morgan cuts to underweight from neutral |
* Five Below Inc FIVE.O: JP Morgan raises target price to $95 from $89 |
* Franklin Bsp Realty Trust Inc FBRT.N: Raymond James raises target price to $15.50 from $15 |
* FTAI Aviation Ltd FTAI.O: RBC raises target price to $143 from $120 |
* General Mills GIS.N: Deutsche Bank raises target price to $73 from $70 |
* General Mills GIS.N: Jefferies raises target price to $73 from $69 |
* General Mills GIS.N: Mizuho raises target price to $72 from $69 |
* General Mills GIS.N: Stifel raises target price to $82 from $70 |
* General Mills GIS.N: Wells Fargo raises target price to $77 from $75 |
* Getty Realty Corp GTY.N: JP Morgan raises target price to $33 from $31 |
* Global Medical REIT Inc GMRE.N: Alliance Global Partners initiates coverage with buy rating |
* Global Medical REIT Inc GMRE.N: Alliance Global Partners initiates coverage with target price $12 |
* Halozyme Therapeutics Inc HALO.O: JP Morgan cuts to neutral from overweight |
* Halozyme Therapeutics Inc HALO.O: JP Morgan raises target price to $57 from $52 |
* Harley-Davidson Inc HOG.N: Citigroup raises target price to $39 from $37 |
* Healthequity Inc HQY.O: RBC raises target price to $100 from $92 |
* Heico Corp HEI.N: BofA Global Research raises price objective to $285 from $250 |
* Helix Energy Solutions Group HLX.N: Raymond James initiates coverage with PT $14 |
* Helix Energy Solutions Group HLX.N: Raymond James initiates coverage with strong buy rating |
* Incyte Corporation INCY.O: Deutsche Bank raises target price to $61 from $60 |
* KB Home KBH.N: BofA Global Research raises price objective to $90 from $75 |
* KKR Real Estate Finance Trust Inc KREF.N: Raymond James raises PT to $14 from $13 |
* Kosmos Energy Ltd KOS.N: Mizuho initiates coverage with neutral rating; target price $5 |
* Lamar Advertising Co LAMR.O: Wells Fargo initiates coverage with equal weight rating |
* Lamar Advertising Co LAMR.O: Wells Fargo initiates coverage with price target $132 |
* Lennar Corp LEN.N: BofA Global Research raises price objective to $190 from $171 |
* Lowe's Companies Inc LOW.N: TD Cowen raises target price to $265 from $240 |
* Lument Finance Trust Inc LFT.N: Raymond James cuts to market perform from outperform |
* MFA Financial Inc MFA.N: Raymond James raises target price to $14.50 from $13 |
* Micron Technology Inc MU.O: Stifel cuts target price to $135 from $165 |
* Micron Technology Inc MU.O: TD Cowen cuts target price to $115 from $160 |
* Murphy USA Inc MUSA.N: JP Morgan cuts to underweight from neutral |
* Murphy USA Inc MUSA.N: JP Morgan raises target price to $435 from $415 |
* Myriad Genetics Inc MYGN.O: Morgan Stanley initiates with equal-weight rating |
* Myriad Genetics Inc MYGN.O: Morgan Stanley initiates with price target $32 |
* Nexpoint Real Estate Finance Inc NREF.N: Raymond James cuts to market perform from strong buy |
* Nextera Energy NEE.N: HSBC raises target price to $95 from $88 |
* Nextera Energy NEE.N: Jefferies initiates coverage with hold rating; price target $87 |
* Nextera Energy NEP.N: Jefferies initiates coverage with buy rating |
* Nextera Energy NEP.N: Jefferies initiates coverage with price target $28 |
* Nike Inc NKE.N: Bernstein cuts target price to $109 from $112 |
* Northern Oil and Gas Inc NOG.N: Mizuho initiates coverage with outperform rating |
* Northern Oil and Gas Inc NOG.N: Mizuho initiates coverage with target price $47 |
* Oceaneering International Inc OII.N: Citigroup raises target price to $30 from $28 |
* Outfront Media Inc OUT.N: Wells Fargo initiates coverage with overweight rating |
* Outfront Media Inc OUT.N: Wells Fargo initiates coverage with target price $22 |
* P&G PG.N: JP Morgan raises target price to $186 from $179 |
* Portland General Electric Company POR.N: Barclays cuts to equal-weight from overweight |
* Portland General Electric Company POR.N: Barclays raises target price to $49 from $48 |
* Prelude Therapeutics Inc PRLD.O: H.C. Wainwright raises to buy from neutral |
* Progyny Inc PGNY.O: JP Morgan cuts target price to $22 from $31 |
* Progyny Inc PGNY.O: Leerink Partners cuts target price to $21 from $25 |
* Progyny Inc PGNY.O: Truist Securities cuts target price to $26 from $33 |
* Pultegroup Inc PHM.N: BofA Global Research raises price objective to $160 from $138 |
* Quidelortho Corp QDEL.O: UBS raises target price to $50 from $42 |
* Quidelortho Corp QDEL.O: UBS raises to neutral from sell |
* Radnet Inc RDNT.O: Jefferies raises target price to $80 from $75 |
* Rayonier Advanced Materials Inc RYAM.N: RBC raises target price to $10 from $9 |
* Redwood Trust Inc RWT.N: Raymond James raises target price to $9.50 from $8.50 |
* Regions Financial RF.N: Citigroup raises target price to $26 from $25 |
* Robinhood Markets Inc HOOD.O: Piper Sandler raises target price to $27 from $23 |
* Safehold Inc SAFE.N: Raymond James raises to outperform from market perform |
* Salesforce Inc CRM.N: Truist Securities raises target price to $315 from $300 |
* Site Centers Corp SITC.N: Stifel raises target price to $65.25 from $65 |
* Smith Douglas Homes SDHC.N: BofA Global Research raises price objective to $40 from $36 |
* Sphere Entertainment Co SPHR.N: Guggenheim raises target price to $63 from $58 |
* SS&C Technologies Holdings Inc SSNC.O: Needham raises target price to $90 from $81 |
* SS&C Technologies Holdings Inc SSNC.O: RBC raises target price to $86 from $75 |
* SS&C Technologies Holdings Inc SSNC.O: UBS raises target price to $90 from $85 |
* Sun Communities Inc SUI.N: Wells Fargo raises target price to $154 from $123 |
* Sunnova Energy International Inc NOVA.N: UBS raises target price to $18 from $10 |
* Talos Energy Inc TALO.N: Mizuho initiates coverage with outperform rating; PT $16 |
* T-Mobile TMUS.O: Evercore ISI raises target price to $220 from $210 |
* T-Mobile TMUS.O: JP Morgan raises target price to $230 from $220 |
* T-Mobile TMUS.O: Oppenheimer raises target price to $215 from $200 |
* T-Mobile TMUS.O: Scotiabank raises target price to $215.5 from $197 |
* Toll Brothers Inc TOL.N: BofA Global Research raises price objective to $165 from $160 |
* Trimble Inc TRMB.O: JP Morgan raises target price to $66 from $58 |
* Trupanion Inc TRUP.O: Northland Capital raises target price to $45 |
* Tyra Biosciences Inc. TYRA.O: Oppenheimer raises target price to $33 from $25 |
* Vail Resorts Inc MTN.N: Stifel cuts target price to $223 from $259 |
* Willscot Holdings Corp WSC.O: Barclays cuts target price to $44 from $50 |
* Willscot Holdings Corp WSC.O: Barclays cuts to equal-weight from overweight |
* World Kinect Corporation WKC.N: JP Morgan raises PT to $32 from $29 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
